19 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
with applicable legal and regulatory requirements, Leerink Partners has adopted policies and procedures to establish and maintain the independence of its
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
the independence of its research department and personnel. As a result, Leerink Partners’ research analysts may hold views, make statements or investment
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
(Communications with Audit Committees Concerning Independence) describing all relationships between the independent registered public accounting firm … communications with the Audit Committee concerning independence. In addition, the Audit Committee discussed with the independent registered public
S-3
EX-1.2
xy0xbfl5x
12 Nov 21
Shelf registration
12:00am
DEF 14A
fdfkjw
26 Apr 21
Definitive proxy
5:00pm
10-K
sv5p0j51526qs7rqtjt2
18 Mar 21
Annual report
6:31am
424B4
rjn31mazgl
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
c941qr1
1 Feb 21
Draft registration statement
12:00am
424B4
xj4ulbu27ijd6
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
zi3s9t8rkm5pwbqs 71t
9 Oct 20
IPO registration
4:59pm
DRS/A
hy7lrahw3lqkddv
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
hf89yl wt
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
wy6wpyo8piin16uz
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next